It also said the alliance will see Moderna invest in R&D in the UK over the next 10 years, including running ... "It is vital we invest in fighting future variants of this disease, as well as ...

We recently published a list of 10 Stocks with Potential to Explode in 2025. In this article, we are going to take a look at ...

Investors who bought $1,000 worth of Moderna’s shares 5 years ago would now be looking at an investment worth $950.86. Here at StockStory, we certainly understand the potential of thematic ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 10 trades ... 35 days. 20-year pro options ...

Moderna recently experienced a notable 10% price increase ... of Moderna stock here. NasdaqGS:MRNA Earnings Per Share Growth as at Mar 2025 Over the past five years, Moderna's total return ...

The pharmaceutical company Moderna ... 5 years in the coming weeks. Moderna CEO Stéphane Bancel anticipated that “given the need for a COVID-19 vaccine in infants and young children, we are ...

Financial giants have made a conspicuous bearish move on Moderna. Our analysis of options history for Moderna (NASDAQ:MRNA) revealed 10 unusual trades. Delving into the details, we found 40% of ...

Moderna was dealt a significant blow in the patent battle over who owns the Covid-19 vaccine last week. In the U.S., the Cambridge drug and vaccine maker hit a roadblock when the Patent Trial and ...

Moderna CEO Stéphane Bancel ... by $2.6 billion and ended the year with $9.5 billion in cash and investments. The company announced prioritization of 10 high-value programs with potential ...